Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity

Evan D. Kharasch, Edward J. Frink, Richard Zager, T. Andrew Bowdle, Alan Artru, Wallace M. Nogami

Research output: Contribution to journalArticlepeer-review

159 Scopus citations

Abstract

Background: Carbon dioxide absorbents degrade sevoflurane, particularly at low gas flow rates, to fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A). Compound A causes renal proximal tubular injury in rats but has had no effect on blood urea nitrogen (BUN) or creatinine concentrations in patients. This investigation compared the effects of low- flow sevoflurane and isoflurane on renal tubular function in surgical patients using conventional (BUN and creatinine) and finer indices of renal injury, specifically those biomakers sensitive for compound A toxicity in rats (glucosuria, proteinuria, and enzymuria [N-acetyl-β-D-glucosaminidase (NAG) and α-glutathione-S-transferase (αGST)]). Methods: Consenting patients with normal preoperative renal function at two institutions were randomized to receive sevoflurane (n = 36) or isoflurane (n = 37) in oxygen and air. Total gas flow was 1 l/min, opioid doses were minimized, and barium hydroxide lime was used to maximize anesthetic degradation. Inspiratory and expiratory compound A concentrations were quantified every 30-60 min. Blood and urine were obtained before and 24-72 h after anesthesia for laboratory evaluation. Results: Sevoflurane and isoflurane groups were similar with respect to age, weight, sex, American Society of Anesthesiologists status, anesthetic duration (3.7 or 3.9 h), and anesthetic exposure (3.6 or 3 minimum alveolar concentration [MAC]-hour). Maximum inspired compound A concentration (mean + standard deviation) was 27 ± 13 ppm (range, 10-67 ppm). Areas under the inspired and expired compound A concentration versus time curves (AUC) were 79 ± 54-ppm-h (range, 10-223 ppm-h) and 53 + 40 ppm-h (range, 6-159 ppm-h), respectively. There was no significant difference between anesthetic groups in postoperative serum creatinine or BUN, or urinary excretion of protein, glucose, NAG, proximal tubular αGST, or distal tubular ΠGST. There was no significant correlation between compound A exposure (AUC) and protein, glucose, NAG, αGST, or ΠGST excretion. Postoperative alanine and aspartate aminotransferase concentrations were not different between the anesthetic groups, and there were no significant correlations between compound A exposure and alanine or aspartate aminotransferase concentrations. Conclusions: The renal tubular and hepatic effects of low-flow sevoflurane and isoflurane were similar as assessed using both conventional measures of hepatic and renal function and more sensitive biochemical markers of renal tubular cell necrosis. Moderate duration low-flow sevoflurane anesthesia, during which compound A formation occurs, appears to be as safe as low-flow isoflurane anesthesia.

Original languageEnglish (US)
Pages (from-to)1238-1253
Number of pages16
JournalAnesthesiology
Volume86
Issue number6
DOIs
StatePublished - 1997

Keywords

  • Anesthesia, low-flow
  • Anesthetics, volatile: isoflurane; sevoflurane
  • Carbon dioxide, absorption: Baralyme
  • Compilations, inhilation anesthesia
  • Degradants: Compound A; PIFE
  • Toxicity: Compound A; hepatic; renal

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity'. Together they form a unique fingerprint.

Cite this